Badaro R - Search Results

1

Cytokines in the treatment of leishmaniasis: from studies of immunopathology to patient therapy.

Ho JL, Badaro R, Hatzigeorgiou D, Reed SG, Johnson WD Jr. Ho JL, et al. Among authors: badaro r. Biotherapy. 1994;7(3-4):223-35. doi: 10.1007/BF01878488. Biotherapy. 1994. PMID: 7865353 Review.

2

Diminished in vitro production of interleukin-1 and tumor necrosis factor-alpha during acute visceral leishmaniasis and recovery after therapy.

Ho JL, Badaró R, Schwartz A, Dinarello CA, Gelfand JA, Sobel J, Barral A, Netto MB, Carvalho EM, Reed SG, et al. Ho JL, et al. Among authors: badaro r. J Infect Dis. 1992 Jun;165(6):1094-102. doi: 10.1093/infdis/165.6.1094. J Infect Dis. 1992. PMID: 1583328 Clinical Trial.

3

The role of interferon-gamma in the treatment of visceral and diffuse cutaneous leishmaniasis.

Badaro R, Johnson WD Jr. Badaro R, et al. J Infect Dis. 1993 Mar;167 Suppl 1:S13-7. doi: 10.1093/infdis/167.supplement_1.s13. J Infect Dis. 1993. PMID: 8433014 Review.

4

Malnutrition as a risk factor for severe visceral leishmaniasis.

Cerf BJ, Jones TC, Badaro R, Sampaio D, Teixeira R, Johnson WD Jr. Cerf BJ, et al. Among authors: badaro r. J Infect Dis. 1987 Dec;156(6):1030-3. doi: 10.1093/infdis/156.6.1030. J Infect Dis. 1987. PMID: 3680989 No abstract available.

5

Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.

Carvalho EM, Badaró R, Reed SG, Jones TC, Johnson WD Jr. Carvalho EM, et al. Among authors: badaro r. J Clin Invest. 1985 Dec;76(6):2066-9. doi: 10.1172/JCI112209. J Clin Invest. 1985. PMID: 3935667 Free PMC article.

6

Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis.

Barral-Netto M, Barral A, Santos SB, Carvalho EM, Badaro R, Rocha H, Reed SG, Johnson WD Jr. Barral-Netto M, et al. Among authors: badaro r. J Immunol. 1991 Jul 1;147(1):281-4. J Immunol. 1991. PMID: 1904902

7

Evaluation of the stability of a soluble intradermal skin test antigen preparation in American visceral leishmaniasis.

Badaró R, Pedral-Sampaio D, Johnson WD Jr, Reed SG. Badaró R, et al. Trans R Soc Trop Med Hyg. 1990 Mar-Apr;84(2):226-7. doi: 10.1016/0035-9203(90)90264-f. Trans R Soc Trop Med Hyg. 1990. PMID: 2389311 No abstract available.

8

Antigen-specific immunosuppression in visceral leishmaniasis is cell mediated.

Carvalho EM, Bacellar O, Barral A, Badaro R, Johnson WD Jr. Carvalho EM, et al. Among authors: badaro r. J Clin Invest. 1989 Mar;83(3):860-4. doi: 10.1172/JCI113969. J Clin Invest. 1989. PMID: 2522103 Free PMC article.

9

Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis.

Jones TC, Johnson WD Jr, Barretto AC, Lago E, Badaro R, Cerf B, Reed SG, Netto EM, Tada MS, Franca TF, et al. Jones TC, et al. Among authors: badaro r. J Infect Dis. 1987 Jul;156(1):73-83. doi: 10.1093/infdis/156.1.73. J Infect Dis. 1987. PMID: 3598227

10

New perspectives on a subclinical form of visceral leishmaniasis.

Badaro R, Jones TC, Carvalho EM, Sampaio D, Reed SG, Barral A, Teixeira R, Johnson WD Jr. Badaro R, et al. J Infect Dis. 1986 Dec;154(6):1003-11. doi: 10.1093/infdis/154.6.1003. J Infect Dis. 1986. PMID: 3782864

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

191 results

Search Page

Filters